Market cap
$0 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 0.00 | 0.00 | -99.50 | -81.78 | -77.77 |
| EBIT | -84.58 | -7.12 | -14.30 | -208.21 | 5.40 |
| Net Profit | -83.68 | -7.10 | -15.27 | 12.30 | 5.84 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-22 | Dec-21 |
| EBIT-Margin
| -941.75 | -580.67 | -65,168.42 | -282.38 | -1,632.10 |
| Net Margin
| -- | -- | -65,278.95 | -- | -- |
| Return on equity
| 6.14 | 10.94 | -147.67 | -58.89 | -99.17 |
| Return on Capital
| 32.20 | 29.38 | -- | -46.61 | -73.69 |
| Return on Assets
| -133.51 | -89.40 | -80.67 | -45.26 | -68.18 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.32 | 0.22 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
-46.61
|
-73.69
|
216.92
|
102.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-147.67
Lower than Peers by 107.27
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-147.67
|
-58.89
|
-99.17
|
176.48
|
101.30
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-80.67
Lower than Peers by 49.69
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-80.67
|
-45.26
|
-68.18
|
-287.10
|
-18.93
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
-65,168.42
Lower than Peers by 65,084.80
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-65,168.42
|
-282.38
|
-1,632.10
|
-910.78
|
-26.55
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
-65,278.95
Lower than Peers by 65,186.28
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-65,278.95
|
-278.08
|
-1,567.46
|
-1,251.77
|
-43.33
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.47
Lower than Peers by 0.47
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-0.47
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
-99.50
Lower than Peers by 153.45
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-99.50
|
3.10
|
-0.55
|
-0.82
|
-0.66
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
-14.30
Lower than Peers by 13.50
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-14.30
|
29.04
|
20.02
|
-524.89
|
82.67
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
-15.27
Lower than Peers by 7.97
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-15.27
|
27.24
|
44.11
|
-426.21
|
72.80
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
0.32
|
0.22
|
0.67
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
0.02
|
0.01
|
0.02
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.05
Lower than Peers by 1.76
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
4.05
|
10.90
|
9.27
|
3.02
|
1.78
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
4.05
Lower than Peers by 1.65
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
4.05
|
10.58
|
8.53
|
2.91
|
1.70
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-4,127.00
Lower than Peers by 4,124.91
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
-4,127.00
|
-10,643.00
|
-1,499.90
|
-293.02
|
-71.45
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
2.63
|
17.95
|
6.99
|
0.97
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.00
Lower than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
0.00
|
0.16
|
0.04
|
0.23
|
0.44
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
12.79
|
61.40
|
22.53
|
61.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
2,774.60
|
1,682.64
|
76.60
|
86.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
2,315.42
|
1,603.78
|
254.13
|
92.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
471.96
|
140.27
|
-155.00
|
54.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
0.02
Lower than Peers by 5.16
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
0.02
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.20
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
0.20
|
0.75
|
0.94
|
0.08
|
0.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
0
Lower than Peers by 146
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Histogen (HSTO)
|
0
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|